Novartis (India) (Q333760)

From geokb

company organization in Hyderabad, India

Language	Label	Description	Also known as
English	Novartis (India)	company organization in Hyderabad, India

Statements

0 references

addresses subject

Health Economics and Quality of Life Assessment

98

1 reference

https://openalex.org/I4210090302

74

1 reference

https://openalex.org/I4210090302

Efficacy and Resistance in CML Treatment

73

1 reference

https://openalex.org/I4210090302

Classification and Treatment of Spondyloarthritis

67

1 reference

https://openalex.org/I4210090302

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

62

1 reference

https://openalex.org/I4210090302

Diagnosis and Pathogenesis of Multiple Sclerosis

59

1 reference

https://openalex.org/I4210090302

Reciprocal Development of TH17 and Treg Cells

57

1 reference

https://openalex.org/I4210090302

Hemophagocytic Lymphohistiocytosis and Related Disorders

56

1 reference

https://openalex.org/I4210090302

Diagnosis and Treatment of Heart Failure

49

1 reference

https://openalex.org/I4210090302

Rheumatoid Arthritis Topics

47

1 reference

https://openalex.org/I4210090302

Pulmonary Drug Delivery Techniques

46

1 reference

https://openalex.org/I4210090302

Developmental Pharmacology in Pediatric Drug Use

45

1 reference

https://openalex.org/I4210090302

Standardisation and Management of COPD

42

1 reference

https://openalex.org/I4210090302

Economics of Pharmaceutical Research and Development

38

1 reference

https://openalex.org/I4210090302

Chimeric Antigen Receptor T Cell Therapy

37

1 reference

https://openalex.org/I4210090302

Epidemiology and Treatment of Childhood Leukemia

36

1 reference

https://openalex.org/I4210090302

Diagnosis and Management of Chronic Cough

36

1 reference

https://openalex.org/I4210090302

Pathophysiology of Glomerular Diseases and Nephrotic Syndromes

35

1 reference

https://openalex.org/I4210090302

Age-Related Macular Degeneration Research

35

1 reference

https://openalex.org/I4210090302

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

32

1 reference

https://openalex.org/I4210090302

Genetic and Clinical Aspects of Hemoglobin Disorders

30

1 reference

https://openalex.org/I4210090302

Role of Complement System in Immune Response

29

1 reference

https://openalex.org/I4210090302

Drug Metabolism and Pharmacogenomics

28

1 reference

https://openalex.org/I4210090302

Management of Hypertension and Cardiovascular Risk Factors

28

1 reference

https://openalex.org/I4210090302

Ocular Manifestations of COVID-19

26

1 reference

https://openalex.org/I4210090302

coordinate location

17°26'8"N, 78°22'53"E

1 reference

https://openalex.org/I4210090302

Republic of India

1 reference

https://openalex.org/I4210090302

official website

http://www.novartis.in/

1 reference

https://openalex.org/I4210090302

0 references

Research Organization Registry ID

0 references

is subsidiary of

Novartis (Switzerland)

1 reference

https://openalex.org/I4210090302

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q333760&oldid=1270170"